Cowan Elvia
SEC CIK 1960048 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PCVX | Vaxcyte, Inc. | SVP, Fin | 27.9K | — | $3.22M | 32 | 2023-03-01 | 2026-09-08 |
Most active insiders at PCVX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | PICKERING GRANT | CEO, Dir | — | $3.63M |
| 2 | GUGGENHIME ANDREW | Pres AND CFO | — | $1.64M |
| 3 | Wassil Jim | EVP, COO, Chief Scientific Ofc | — | $1.43M |
| 4 | Dhaliwal Harpreet S. | Chief Technical Ops Off | — | $1.39M |
| 5 | Cowan Elvia | SVP, Fin | — | $988.6K |
| 6 | Jodar Luis | Chief Medical Off | — | — |
| 7 | Lee Jacks | Dir | — | — |
| 8 | Loxam Teri | Dir | — | — |
| 9 | Furey John | Dir | — | — |
| 10 | Paya Carlos V | Dir | — | — |
Transactions 32
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-09 17:52 | 2026-09-08 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, CAO, Fin | F - Tax | $60.36 | -1,327 | 27.9K | -5% | -$80.1K | |
| M | 2026-09-02 19:54 | 2026-08-31+ | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, CAO, Fin | F - Tax | $61.22 | -569 | 29.2K | -2% | -$34.8K |
| DT | 2026-04-08 16:32 | 2026-04-07 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, CAO, Fin | M - OptEx | $25.92 | +3,000 | 32.0K | +10% | +$77.8K |
| DT | 2026-04-08 16:32 | 2026-04-07 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, CAO, Fin | S - Sale+OE | $60.00 | -3,000 | 29.0K | -9% | -$180.0K |
| M | 2026-03-18 | 2026-03-17 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, CAO, Fin | S - Sale | $55.58 | -1,892 | 29.4K | -6% | -$105.2K |
| D | 2026-03-11 | 2026-03-11 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, CAO, Fin | S - Sale+OE | $58.59 | -2,500 | 30.9K | -7% | -$146.5K |
| D | 2026-03-11 | 2026-03-11 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, CAO, Fin | M - OptEx | $25.92 | +2,500 | 33.4K | +8% | +$64.8K |
| D | 2026-03-11 | 2026-03-09 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, CAO, Fin | F - Tax | $59.32 | -495 | 30.9K | -2% | -$29.4K |
| D | 2026-03-02 | 2026-02-26 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, CAO, Fin | A - Grant | $0.00 | +10.7K | 24.2K | +79% | $0 |
| DM | 2026-03-02 | 2026-02-28+ | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, CAO, Fin | F - Tax | $61.98 | -569 | 31.4K | -2% | -$35.3K |
| D | 2026-03-02 | 2026-02-26 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, CAO, Fin | M - OptEx | $25.92 | +7,716 | 31.9K | +32% | +$200.0K |
| M | 2025-12-29 | 2025-12-23 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, Fin | S - Sale | $47.92 | -11.6K | 21.2K | -35% | -$557.0K |
| 2025-12-29 | 2025-12-23 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, Fin | G - Gift | $0.00 | -1,000 | 13.5K | -7% | $0 | |
| 2025-09-10 | 2025-09-08 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, Fin | F - Tax | $32.41 | -482 | 26.2K | -2% | -$15.6K | |
| M | 2025-09-04 | 2025-09-02 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, Fin | F - Tax | $31.56 | -567 | 27.0K | -2% | -$17.9K |
| D | 2025-08-29 | 2025-09-07 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, Fin | A - Grant | $0.00 | +2,810 | 27.2K | +12% | $0 |
| D | 2025-03-03 | 2025-02-27 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, Fin | A - Grant | $0.00 | +5,379 | 24.7K | +28% | $0 |
| DM | 2025-03-03 | 2025-02-28+ | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, Fin | F - Tax | $72.49 | -567 | 24.1K | -2% | -$41.1K |
| D | 2024-12-18 | 2024-12-16 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, Fin | M - OptEx | $25.92 | +7,716 | 19.3K | +67% | +$200.0K |
| D | 2024-09-05 | 2024-09-03 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, Fin | M - OptEx | $25.92 | +5,000 | 17.7K | +39% | +$129.6K |
| D | 2024-09-05 | 2024-09-03 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, Fin | S - Sale+OE | $107.67 | -5,000 | 12.7K | -28% | -$538.4K |
| D | 2024-09-05 | 2024-09-03 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, Fin | F - Tax | $110.15 | -1,145 | 11.6K | -9% | -$126.1K |
| D | 2024-07-17 | 2024-07-16 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, Fin | M - OptEx | $25.92 | +5,000 | 17.7K | +39% | +$129.6K |
| D | 2024-07-17 | 2024-07-16 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, Fin | S - Sale+OE | $85.00 | -5,000 | 12.7K | -28% | -$425.0K |
| D | 2024-07-09 | 2024-07-08 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, Fin | M - OptEx | $25.92 | +5,000 | 17.7K | +39% | +$129.6K |
| D | 2024-07-09 | 2024-07-08 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, Fin | S - Sale+OE | $80.00 | -5,000 | 12.7K | -28% | -$400.0K |
| DM | 2024-03-04 | 2024-03-01 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, Fin | S - Sale+OE | $74.08 | -11.7K | 17.4K | -40% | -$865.1K |
| D | 2024-03-04 | 2024-03-01 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, Fin | M - OptEx | $25.92 | +11.0K | 24.2K | +84% | +$285.1K |
| D | 2024-03-04 | 2024-02-29 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, Fin | A - Grant | $0.00 | +5,400 | 13.2K | +70% | $0 |
| D | 2024-03-04 | 2024-03-02 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, Fin | F - Tax | $71.55 | -324 | 12.2K | -3% | -$23.2K |
| 2023-09-06 | 2023-09-05 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, Fin | F - Tax | $51.00 | -627 | 7,301 | -8% | -$32.0K | |
| D | 2023-03-03 | 2023-03-01 | PCVX | Vaxcyte, Inc. | Cowan Elvia | SVP, Fin | A - Grant | $0.00 | +7,250 | 7,250 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations